Meet the leaders and members of the Molecular Biology and Cancer Genetics research program at the OSUCCC – James who promote improved screening, diagnosis, prognosis and treatment.

Leaders

Matthew Ringel, MD

Dr. Ringel's research interests include molecular mechanisms involved in thyroid cancer invasion and metastasis; with an active interest in new drug testing for thyroid cancer therapy.

Read More

Members

Mohamed Abdel-Rahman, MD, PhD

Mohamed Abdel-Rahman, MD, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where he focuses his research on molecular diagnosis of ocular melanoma, identification of novel targets for ocular melanoma therapy and hereditary predisposition to ocular

Read More

Rene Anand, MS, PhD

As a member of the Molecular Biology and Cancer Genetics team at the OSUCCC – James, Rene Anand, PhD, along with his laboratory, has recently developed human adult stem cell (iPSC) derived models of cancer, autism and Alzheimer’s disease. In particular, Dr. Anand’s work focuses on understanding.

Read More

Paul Andreassen, PhD

Paul Andreassen, PhD, is a member of the OSUCCC – James Molecular Biology and Cancer Genetics Program. He is based at Cincinnati Children’s Hospital Medical Center.

Read More

Rami Aqeilan, PhD

Rami Aqeilan, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James. His work explores the molecular aspect of cancer biology in an effort to uncover the genes that contribute to transforming an incipient cancer cell.

Read More

Kellie Archer, PhD

Kellie Archer, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James and chair of the Division of Biostatistics in The Ohio State University College of Public Health. Her work focuses on developing statistical methods and software to analyze data from.

Read More

Bruce Aronow, PhD

As a member of the OSUCCC – James Molecular Biology and Cancer Genetics Program, Bruce Aronow, PhD, works with investigators in diverse areas to use technologies that measure gene activity, variation and mutation across the genome. He is based at Cincinnati Children’s Hospital Medical Center.

Read More

Christin Burd, PhD

Christin Burd, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where she focuses her research on improving our understanding of the connections between cancer and aging. Her team’s goal is to bridge bench science and clinical trials.

Read More

Hakan Cam, PhD

Cancer is a genetic disorder caused by mutations in genes critically involved in the control of cell proliferation. Long-lived organisms, such as humans, have evolved strategies to restrict the development of potentially malignant cells.

Read More

Lei Cao, PhD

Lei Cao, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James. Dr. Cao’s research has characterized a novel brain-fat axis underlying the antiobesity and anticancer phenotypes involved in a complex environment.

Read More

Colleen Cebulla, MD, PhD

Colleen Cebulla, MD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where her research is focused on retinal detachments and uveal melanoma. Her research team has identified that over 10 percent of patients with uveal melanoma have a heritable cancer.

Read More

Dawn Chandler, PhD

Dawn Chandler, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where her work focuses on the regulation of pre-mRNA splicing and how its disruption can lead to pediatric diseases such as cancer. In one recent study, her team’s research identified.

Read More

Lionel Chow, MD, PhD

Lionel Chow, MD, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where his research focuses on glioblastoma multiforme and angiosarcoma. Dr. Chow’s work has led to the development of robust laboratory models for this disease that are now used to.

Read More

Susan Cole, PhD

The Notch signaling pathway plays key roles in human development and disease. Disregulation of Notch signaling is frequently seen in human cancers, for instance, activating Notch mutations are seen in over 50% of juvenille T-ALL cases.

Read More

Vincenzo Coppola, MD

Vincenzo Coppola, MD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James. He is also the director of the Genetically Engineered Mouse Modeling Core (GEMMC) Shared Resource to assist other OSUCCC members in generating mouse models of human cancer and to study.

Read More

Carlo Croce, MD

Dr. Croce studies the molecular changes in genes that lead to cancer. He is particularly interested in the early changes of malignancy and how they might serve as targets for new treatment and preventive agents.

Read More

Biplab Dasgupta, PhD

Biplab Dasgupta, PhD, a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, is based at Cincinnati Children’s Hospital Medical Center. His research seeks to learn how neural cell/stem-cell metabolic and energy status is linked to cell cycle, lineage commitment.

Read More

Albert de la Chapelle, MD, PhD

Research in Dr. de la Chapelle’s laboratory focuses on the mapping, cloning, and characterization of high- and low-penetrance genes for cancer predisposition. When new genes are identified, studies are directed to determine the pathophysiological role of the proteins or RNA molecules they encode.

Read More

Nicholas Denko, MD, PhD

Nicholas Denko, MD, PhD, a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, is the co-holder of two U. S.

Read More

James DeWille, PhD

Dr. DeWille's research includes the molecular mechanisms of growth regulation.

Read More

Richard Fishel, PhD

Dr Fishel’s research interests includes DNA Repair defects and Genomic Instability in cancer development; biophysical chemistry of DNA repair; and single molecule imaging in vitro and in vivo. His laboratory studies the mechanisms, genetics, regulation, and consequences of DNA repair and genome.

Read More

Harold Fisk, PhD

Centrosomes are microtubule-organizing structures that coordinate mitotic spindle assembly and chromosome segregation. Centrosome aberrations are found in a variety of tumors, and are associated with tumorigenesis in breast cancer, prostate cancer, and leukemia.

Read More

Michael Freitas, PhD

Michael Freitas, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where he focuses his research on proteomics. He also is involved in biomarker discovery and validation, as well as bioinformatics for mass spectrometry-based proteomics.

Read More

Ramesh Ganju, PhD

Ramesh Ganju, PhD, is a professor and vice chair of experimental pathology in the Department of Pathology at Ohio State, where he is also a researcher in the Molecular Biology and Cancer Genetics Program at the OSUCCC – James. The major focus of Dr. Ganju’s laboratory is to elucidate.

Read More

Samir Ghadiali, PhD

As part of an NSF funded project, Dr. Ghadiali uses engineering, biophysical and molecular/cell biology techniques to identify how biomechanical properties of both cancer cells and the tumor microenvironment (TME) influence oncogenic epithelial to mesenchymal transition (EMT). Dr. Ghadiali also.

Read More

Paul Goodfellow, PhD

The research of Paul Goodfellow, PhD, a professor in the Department of Obstetrics and Gynecology at Ohio State and a member of the OSUCCC – James Molecular Biology and Cancer Genetics Program, centers on understanding the role that loss of DNA-mismatch repair plays in uterine tumor initiation and

Read More

Venkat Gopalan, PhD

My laboratory has a long-standing interest in RNase P, an endonuclease involved in tRNA 5’- biogenesis. Human RNase P (nuclear) employs a protein-aided ribozyme to process precursortRNAs and long non-coding RNAs (lncRNAs).

Read More

John Gunn, PhD

John Gunn, PhD, is a professor in the Department of Microbial Infection and Immunity at Ohio State and a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where his research centers on microbial resistance to innate immunity. In particular, he is focused on the.

Read More

Tsonwin Hai, PhD

Tsonwin Hai, PhD, is a professor in the Department of Biological Chemistry and Pharmacology at Ohio State, and a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James. Her research team focuses on maladaptive processes in the development of disease, with a focus on.

Read More

Heather Hampel, MS, CGC

Heather Hampel, MS, LGC, is a professor and associate director of the Division of Human Genetics at Ohio State, and a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where she also serves as associate director for biospecimen research. Dr. Hampel’s research.

Read More

Paul Herman, PhD

Dr. Herman's lab is interested in understanding the mechanisms Herman Lab Memberscontrolling eukaryotic cell growth and proliferation. The primary focus has been on the G0-like resting states that cells enter when conditions are not conducive to continued growth.

Read More

F. Kay Huebner, PhD

Kay Huebner, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where her research focuses on investigating and defining the biological functions of tumor-suppressor proteins. In particular, she is interested in two of the most frequently inactivated.

Read More

Jaime Imitola, MD

A member of the OSUCCC – James Molecular Biology and Cancer Genetics Program, Jaime Imitola, MD, directs the Neural Stem Cell Laboratory. His work focuses on understanding the molecular mechanisms involving cross talk between the immune system and neural stem cells genomics in models of multiple.

Read More

Sissy Jhiang, PhD

Sissy Jhiang, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where her research focuses on molecular biology, cellular biology, genetic-engineered animal models, small-animal imaging modalities and nanobiotechnology. In particular, she is exploring.

Read More

Daniel Jones, MD, PhD

Dr. Jones' research interests center on models for mouse models, functional screens and classification approaches for attributing oncogenic and tumor potential of mutations identified in genomic screens and clinical sequencing assays. Specific model system are PTEN-haploinsufficient colon cancer.

Read More

Tatiana Kalin, MD, PhD

multiple transgenic and knockout mouse models to study the specific role of several transcription factors in different cell populations, including lung epithelial cells, macrophages, fibroblasts, pericytes and endothelial cells. My laboratory is interested in identifying critical regulatory.

Read More

Lawrence Kirschner, MD, PhD

Lawrence Kirschner, MD, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where his research focuses on endocrine tumor genetics. He is particularly interested in understanding how dysregulation of PKA contributes to tumorigenesis in cAMP-responsive.

Read More

Ashish Kumar, MD, PhD

Ashish Kumar, MD, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, and is based at Cincinnati Children’s Hospital Medical Center. His research focuses on blood cancers of childhood, specifically infant leukemia, and Langerhans Cell Histiocytosis.

Read More

Takeshi Kurita, PhD

Takeshi Kurita, PhD, is a member of the OSUCCC – James Molecular Biology and Cancer Genetics Program. His research explores the molecular mechanisms of development and carcinogenesis of the reproductive organs.

Read More

Nam Yong Lee, PhD

Nam Young Lee, PhD, is a member of the OSUCCC – James Molecular Biology and Cancer Genetics Program. Dr. Lee’s research explores how transforming growth factor beta signaling regulates vascular functions during tumor development and metastasis.

Read More

Jennifer Leight, PhD

As a member of the Molecular Biology and Cancer Genetics Program at OSUCCC – James, Jennifer Leight, PhD, uses innovative biomaterials to investigate fundamental questions regarding the tumor microenvironment and the regulation of cancer cell function. She has also developed new methods for.

Read More

Stephen Lessnick, MD, PhD

As Director of the Center for Childhood Cancer and Blood Disorders at Nationwide Children's Hospital, Dr. Lessnick leads a team of pediatric researchers who are working to expand the understanding of the development of childhood cancer and to transform diagnostic and treatment strategies. He also.

Read More

Lang Li, PhD

I have two cancer related research areas. In the first area, I use electronic medical record data sources and medical informatics approaches to investigate risk factors that predict either drug efficacy or adverse drug events.

Read More

Zaibo Li, MD, PhD

Zaibo Li, MD, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where his research focuses on breast and gynecologic pathology. In particular, he is interested in breast cancer biomarkers, especially HER2 and checkpoint immune markers, as well as.

Read More

Q Richard Lu, PhD

Dr. Lu's lab has identified a novel tumor suppressor gene GNAS in medulloblastoma and defined an oncogenic role of Olig2 in glioma initiation and progression. Their research goal is to identify the critical molecules and pathways that drive tumorigenesis in glioblastoma and medulloblastoma, and.

Read More

K John McLaughlin, PhD

K. John McLaughlin, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where his research focuses on epigenetics, stem cells and therapeutic transplant models.

Read More

Wayne Miles, PhD

Wayne Miles, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where his research seeks to identify mechanisms that enable cancer cells to overcome cellular stresses associated with oncogenic growth. In particular, he is focused on how the loss of the.

Read More

Eugene Oltz, PhD

Dr. Oltz studies the genetic, epigenetic, and topological mechanisms that govern gene expression programs in normal and transformed lymphocytes. Insights from these studies are being leveraged to create targeted epigenetic therapeutics for cancer and autoimmunity.

Read More

Jose Otero, MD, PhD

Jose Otero, MD, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where his research focuses on induced pluripotent stem cells, neural stem cells, cell-cycle control of stem cells and molecular diagnostics. One of his recent studies showed a promising.

Read More

Ioanna Papandreou, PhD

The dysfunctional tumor vasculature and the deregulated cancer cell proliferation create areas of oxygen- and nutrient- deprivation in solid tumors. Cells within the tumor respond to these microenvironmental stresses by activating adaptive mechanisms that allow malignant progression under such.

Read More

Jeffrey Parvin, MD, PhD

Jeffrey Parvin, MD, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where his research focuses on biological processes in breast cancer. In particular, he investigates the pathways regulated by the BRCA1 tumor-suppressor proteins, as well as the.

Read More

Yuri Pekarsky, PhD

Yuri Pekarsky, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where his research focuses on mature T-cell leukemia chromosomal rearrangements. Through the investigation of one chromosomal rearrangement, two related genes—TCL1 and TCL1b—have been.

Read More

John Phay, MD

Dr. Phay has two main research projects. The first is examining a novel AMPK activator for the treatment of thyroid cancer.

Read More

Kamal Pohar, MD

Dr. Pohar’s research interest include: Bladder cancer, Testicular cancer, Genetic and epigenetic changes contributing to progression of bladder cancer, and Developing clinical and biologic databases in bladder cancer.

Read More

Nancy Ratner, PhD

The long term interest of the Ratner laboratory is to define the interactions between glial cells and axons during nervous system development and how those interactions go awry in disease, with the goal of providing novel therapies to patients with nervous system diseases. Neurofibromatosis type.

Read More

Eduardo Reategui, PhD

The Reátegui research group focuses on the development of microtechnology platforms for the isolation and characterization of circulating tumor biomarkers for cancer diagnostics and therapeutics. Circulating biomarkers are currently extensively studied in the cancer research field because of their.

Read More

Grzegorz Rempala, PhD

Dr. Rempala's lab conducts high quality, original research in the areas of mathematical and applied statistics relevant to public health.

Read More

Thomas Scharschmidt, MD

Thomas Scharschmidt, MD, is a member of the Molecular Biology and Cancer Genetics Program at OSUCCC – James, where his research focuses on adjuvant chemotherapy for management of soft tissue and bone sarcomas. He also investigates outcomes of limb reconstructions, oncology implant design.

Read More

Daniel Schoenberg, PhD

The Schoenberg lab is nationally recognized for discoveries in fundamental mechanisms of post-transcriptional gene regulation and the application of this knowledge to signal transduction, cancer and inherited diseases. The four projects currently under study look at the molecular mechanisms of.

Read More

Nilay Shah, MD

The primary interest of Dr. Shah’s lab is the set of aberrations that lead to embryonic cancers, i. e.

Read More

Lawrence Shirley, MD, MS

Dr. Shirley is a surgical oncologist who researches the role of the protein integrin-linked kinase (ILK) in the progression of aggressive thyroid cancers. Dr. Shirley's lab is actively investigating the etiology for increased ILK expression in these fibroblasts, while also examining the role of.

Read More

Amanda Simcox, PhD

Dr. Simcox studies EGF receptor signaling in the early wing disc. This simple system is about 30 cells in a just hatched larva and grows to about 150 cells in two days.

Read More

Gina Sizemore, PhD

Research in the Sizemore lab integrates in vitro and in vivo modeling of the brain metastatic tumor microenvironment (TME) to provide mechanistic insight into how the brain metastatic TME contributes to breast cancer metastatic progression. Current studies aim to elucidate whether platelet derived.

Read More

Steven Sizemore, PhD

Dr. Sizemore's research focuses on elucidating the mechanisms of cancer metastasis and developing novel therapies to improve outcomes for patients with metastatic disease. Metastatic breast cancer and metastatic soft tissue sarcoma are the areas of concentration for his research which combines.

Read More

Jonathan Song, PhD

Dr. Song uses microscale engineering technology to reconstitute the microarchitecture of living tissue in vitro to systematically investigate how certain components of tumor microenvironment regulate angiogenesis. One of his research interests is understanding how the determinants of tumor blood.

Read More

Anne Strohecker, PhD

Dr. Strohecker is interested in understanding how autophagy, a program that regulates protein and organelle quality control, impacts tumorigenesis. Her projects focus on (i) the identification of novel autophagy regulators and their functional relevance for lung tumorigenesis, and (ii) the role.

Read More

Vish Subramaniam, PhD

The focus of Dr. Subramaniam’s research is on interactions between low frequency (< 1 MHz) electromagnetic waves and tissues and cells. This research ranges from fundamental studies to pre-clinical applications.

Read More

Matthew Summers, PhD

Dr. Summers' research focuses on the mechanisms of genome maintenance, in particular understanding altered or heightened responses to stress occurring during replication or mitosis in transformed cells. His lab strives to gain novel insight into these differences in order to improve the treatment.

Read More

Maiko Suzuki, PhD, DDS

My research interest is sirtuin-1 (SIRT1) functions in oral cancer metastasis and drug resistance. My ultimate goal is to apply basic research achievement for novel preventive or therapeutic strategies to cure patients.

Read More

Amanda Toland, PhD

Dr. Toland's lab is interested in identifying naturally occurring variations in genes that affect human cancer susceptibility in order to understand how tumors grow and develop, to identify new targets for cancer therapy and prevention, and to better define a person’s risk of getting cancer. An.

Read More

Monica Venere, PhD

The overarching goal of Dr. Venere's laboratory is to elucidate points of fragility for glioblastoma using cell and molecular biology as well as animal models and exploit these findings to develop new treatment modalities and/or improve on current standard of care therapies and thereby alter

Read More

Jing Jenny Wang, PnD

Research in the Wang laboratory includes basic and translational research projects, aiming to 1) understand the molecular mechanisms of colorectal cancer metastasis, recurrence, tumor dormancy and drug resistance, 2) identify and validate novel therapeutic targets using cell culture, organoids,

Read More

Ruoning Wang, PhD

The fundamental interest of Dr. Wang's labe is to understand how eukaryotic cell integrates various extracellular and intrinsic signals/cues to dictate cellular fate (cell proliferation, death, growth and differentiation). In particular, we focus on understanding the impact of the interplay.

Read More

Robin Wharton, PhD

We study post-transcriptional gene regulation during development in the germ line of the model system Drosophila melanogaster. Two proteins-- Nanos and Pumilio-- collaborate to repress translation of CyclinB mRNA in the primordial germ cells, thereby blocking proliferation.

Read More

Terence Williams, MD, PhD

Dr. Williams' laboratory research interests center around lung and gastrointestinal (GI) malignancies. They are interested in the molecular biology and genetics of DNA repair and DNA damage response, those pathways which dictate tumor aggressiveness such as invasion and metastasis, and those.

Read More

Richard Wilson, PhD

D. Wilson is interested in utilizing the tools & technologies of modern genomics, and developing new derivatives thereof, to ask and answer questions of cancer biology that have eluded previous researchers.

Read More

Jian-Qiu Wu, PhD

The goal of Dr. Wu's laboratory is to understand the roles of cytoskeletal and signaling proteins in cellular asymmetry and cell division in normal and cancer cells. We are focusing on the molecular mechanisms of cytokinesis in the fission yeast S.

Read More

Li Wu, PhD

Dr. Wu's lab aims to better understand the mechanisms of epigenetic silencing of SAMHD1 in CTCL to develop novel therapeutic approaches. Our recent findings suggest that epigenetic silencing of SAMHD1 in malignant CD4+ T-cells contributes to uncontrolled T-cell growth in CTCL.

Read More

Sung Yoon, PhD

Sung Yoon, PhD, is a member of the Molecular Biology and Cancer Genetics Program at OSUCCC – James, where her research focuses on understanding how the balance between cell survival and death is maintained in the adult nervous system. In particular, she is exploring the role of stress kinase JNK.

Read More

Jacob Yount, PhD

Jacob Yount, PhD, is a member of the Molecular Biology and Cancer Genetics Program at OSUCCC – James, where his research focuses on developing and implementing tools to study protein post-translational modifications. In particular, he explores protein lipidations such as palmitoylation.

Read More

Junran Zhang, MD, PHD

The focus of Dr. Zhang's research is to study the DDR and to investigate how DDR can be exploited for personalized medicine. The DNA damage can be caused indirectly or directly by ionizing radiation (IR), replication stress-generating chemotherapeutic drugs, targeted therapy agents and.

Read More

Yan Zhang, PhD

High-throughput genomic and proteomic data has been and is being generated in cancer studies. My research interests span statistical and computational methods and their applications to genomic and proteomic research.

Read More

Weiqiang Zhao, MD, PhD

Dr. Zhao's research interest include investigating and validating biomarkers in molecular pathogenesis, diagnosis, and target intervention in cancer and leukemia. One of his projects is to study the role of isoform 6 of IKZF1 gene in leukemia or lymphoma progression which has been shown to be.

Read More

Please enter a keyword (i.e. Name, Research Interest) or choose a Research Program

OR

Please enter a keyword (i.e. Name, Cancer Type) or choose a Principle Investigator

OR

Find a Scientific Publication

Search for Clinical Trials